AU580569B2 - Immunization - Google Patents

Immunization

Info

Publication number
AU580569B2
AU580569B2 AU34980/84A AU3498084A AU580569B2 AU 580569 B2 AU580569 B2 AU 580569B2 AU 34980/84 A AU34980/84 A AU 34980/84A AU 3498084 A AU3498084 A AU 3498084A AU 580569 B2 AU580569 B2 AU 580569B2
Authority
AU
Australia
Prior art keywords
immunization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU34980/84A
Other versions
AU3498084A (en
Inventor
Gregory Austin Tannock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gregory Tannock
Original Assignee
Newcastle Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newcastle Innovation Ltd filed Critical Newcastle Innovation Ltd
Priority to AU34980/84A priority Critical patent/AU580569B2/en
Publication of AU3498084A publication Critical patent/AU3498084A/en
Application granted granted Critical
Publication of AU580569B2 publication Critical patent/AU580569B2/en
Assigned to Gregory Tannock reassignment Gregory Tannock Alteration of Name(s) in Register under S187 Assignors: UNIVERSITY OF NEWCASTLE RESEARCH ASSOCIATES LIMITED, THE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
AU34980/84A 1983-11-04 1984-11-02 Immunization Ceased AU580569B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU34980/84A AU580569B2 (en) 1983-11-04 1984-11-02 Immunization

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPG2218 1983-11-04
AUPG221883 1983-11-04
AU34980/84A AU580569B2 (en) 1983-11-04 1984-11-02 Immunization

Publications (2)

Publication Number Publication Date
AU3498084A AU3498084A (en) 1985-05-16
AU580569B2 true AU580569B2 (en) 1989-01-19

Family

ID=25623029

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34980/84A Ceased AU580569B2 (en) 1983-11-04 1984-11-02 Immunization

Country Status (1)

Country Link
AU (1) AU580569B2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU503714B2 (en) * 1974-10-22 1979-09-20 Anvar Oil-free adjuvant composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU503714B2 (en) * 1974-10-22 1979-09-20 Anvar Oil-free adjuvant composition

Also Published As

Publication number Publication date
AU3498084A (en) 1985-05-16

Similar Documents

Publication Publication Date Title
AU2936184A (en) 13alpha-gonanes
AU2773884A (en) Pyridyl- and pyrimidyl- sulphonamides
AU2810384A (en) Nivamaler
AU2836184A (en) Desensitiser
AU2670684A (en) N-aryl-alpha-amino-carboxamides
AU2768784A (en) Carry-cot
AU2867284A (en) Korpertrainingsgerat
AU2809484A (en) N-pyridylindoles
AU2478684A (en) Branch-copolymers
AU2449484A (en) N-piperazinylalkanoylanilides
AU2692984A (en) Benzoquinolizines
AU2952484A (en) 6-deoxyanthracyclines
AU3025784A (en) 3-phenoxy-1-azetidinecarboxamides
AU2743684A (en) 4-phenyl-tetrahydro-furano-pyridines
AU2445584A (en) D-homosteroids
AU2543484A (en) Sky-light
AU2454184A (en) Aroylimidazolones
AU2917784A (en) Thiazolo - and thiazinobenzimidazoles
AU3036384A (en) Mini - somatostatins
AU2580684A (en) Pyridyl-benzoxazines
AU2610884A (en) Benzobisoxazinetetra-ones
AU2814784A (en) Larmsystem
AU2682284A (en) Diphenylazomethines
AU2923884A (en) 1-phenoxy-3-hydroxyindolyl-alkylamino-2-propanols
AU2745984A (en) N-cyclohexadienyl-chloroacetamides